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The human alcohol dehydrogenase 5 gene (also known
as the formaldehyde dehydrogenase gene, ADH5/FDH)
has a GC-rich promoter with many sites at which tran-
scription factors bind. A minimal promoter extending
from 234 base pairs (bp) to 161 bp directs high levels of
transcription in several different cells, consistent with
the ubiquitous expression of the gene. Nearly the entire
minimal promoter can be bound by Sp1. We analyzed the
transcriptional regulation of ADH5/FDH by members of
the Sp1 multigene family. Two core cis-elements (222 bp
to 122 bp) had the highest affinity for Sp1. Mutagenesis
revealed that these cis-elements are critical for tran-
scriptional activation. The zinc-finger domains of Sp3
and Sp4 also bind selectively to the core cis-elements. In
Drosophila SL2 cells, which lack endogenous Sp1, the
minimal promoter cannot drive transcription. Introduc-
tion of Sp1 activated transcription over 50-fold, suggest-
ing that Sp1 is critical in the initiation of transcription.
Neither Sp3 nor Sp4 was able to activate transcription
in those cells, and transcriptional activation by Sp1 was
repressed by Sp3 or Sp4. These data suggest that Sp3
and Sp4 can repress transcription by competing with
Sp1 for binding to the core cis-elements. The content of
Sp1, Sp3, and Sp4 in different cells may be critical fac-
tors regulating transcription of the ADH5/FDH gene.
The regulated transcription of a typical eukaryotic gene is
governed by the combined action of multiple sequence-specific
DNA-binding proteins (1, 2). The information provided by these
proteins is ultimately communicated to RNA polymerase II,
resulting in a precise transcription initiation frequency.
Sp1 is a well characterized sequence-specific DNA-binding
protein that plays a role in the transcription of many cellular
and viral genes that contain GC boxes (KRGGMGKRRY) in
their promoters (3, 4). This includes numerous housekeeping
genes, with high G1C content in their promoters (5). Addi-
tional human and rodent transcription factors (Sp2, Sp3, Sp4)
similar in structural and transcriptional properties to Sp1 have
been cloned, and form an Sp1 multigene family (6–9). Sp1, Sp3,
and Sp4 have a highly conserved zinc-finger DNA binding
domain close to the C terminus and contain glutamine- and
serine/threonine-rich amino acid stretches in the N-terminal
region (10). Sp1, Sp3, and Sp4 can bind to the same recognition
sequence (GC boxes) with identical affinity (6). Sp1 and Sp4
generally act as transcriptional activators, while Sp3 generally
acts as a repressor, and rarely as an activator (10–16). Sp2 has
a DNA-binding specificity different from that of Sp1, Sp3, and
Sp4. The Sp1 multigene family is an important regulator of the
cell cycle, differentiation, and development (9, 15–17).
We previously cloned and characterized the ADH5/FDH1
gene (18, 19), which encodes the human class III x-alcohol dehy-
drogenase (ADH, EC 1.1.1.1) that is also the NAD1/glutathione-
dependent formaldehyde dehydrogenase (FDH, EC 1.2.1.1) (20).
This gene is believed to be the ancestral ADH gene (21). It is
important in the oxidation of various alcohols and of formalde-
hyde (in the presence of glutathione) (see Refs. 19 and 22–24,
and references therein). ADH5/FDH is ubiquitously expressed,
although to different levels in different cells (22, 23). The
ADH5/FDH promoter is very different from those of other
ADH genes, which are expressed in different tissue-specific
patterns. It is very rich in GC base pairs (73% up to 2200 bp;
82% in the minimal promoter) and does not contain either a
TATA or CCAAT box (18). It thus has the characteristics of a
housekeeping gene (25, 26). The regulation of housekeeping
genes is poorly understood.
The very small DNA fragment extending to 234 bp of
ADH5/FDH is a strong promoter in all cells tested (19). Pro-
moter elements from 238 bp to 122 bp, flanking the transcrip-
tional start site, are footprinted by all nuclear extracts tested,
and nearly the entire minimal promoter can be bound by Sp1
(Fig. 1) (19). This is an unusual configuration of GC boxes
flanking the transcription start site. Although this may lead
one to expect a simple promoter, the ADH5 promoter is sur-
prisingly complex and the regulation of this ubiquitously ex-
pressed gene is quite complicated (19).
Here we test whether the members of the Sp1 multigene
family recognize the same cis-acting elements on the minimal
promoter, and examine the roles they play in transcriptional
regulation. Analyses of DNA-protein interactions in vitro and
in vivo demonstrate that the members of this multigene family
compete for binding, with different effects upon transcription.
These data in part explain the ubiquitous expression of the
gene and how different levels of expression are achieved in
different tissues. This may have significant implications in
understanding how many housekeeping genes can be regulated
(19, 22, 23).
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EXPERIMENTAL PROCEDURES
Plasmid Constructs—pGL luciferase, pCAT Control and pCAT Basic
were purchased from Promega (Madison, WI). pCAT Control contains
the SV40 promoter, enhancer, and CAT coding sequence. pCAT Basic
does not have an eukaryotic promoter and enhancer. pGL luciferase
contains a firefly luciferase gene driven by a cytomegalovirus (CMV)
promoter in a vector called pcDNA I (Invitrogen, San Diego, CA). pCAT
5–2, which contains the ADH5/FDH minimal promoter (234 bp to 161
bp) in front of the CAT coding region in pCAT Basic, and pCAT AX (264
bp to 161 bp) are described elsewhere (19). pCMVSp1 and pPacSp1
were generous gifts from Dr. Robert Tjian (27). pCMVSp3, pCMVSp4,
pPacSp3, and pPacSp4 were kindly provided by Dr. Guntram Suske
and Dr. Luigi Lania (10, 13, 14). pRatSp1 and BTEB was kindly pro-
vided by Dr. Fujii-Kuriyama (7). pCMVAP2 was provided by Dr. Trevor
Williams (28). The pPac vector used to construct pPac luciferase con-
tains the Drosophila actin promoter, and was kindly provided by Dr.
Carl Thummel (University of Utah).
Nuclear Extracts and Transcription Factors—Nuclear extracts from
cultured HeLa cells were made according to Shapiro et al. (29). HeLa
cell nuclear extract and the purified transcription factors Sp1 and AP2
were purchased from Promega. Antibodies to Sp1 (PEP2), Sp3, Sp4, and
AP2 were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). Antibody to the Ku antigen was kindly provided by Dr. Westly
Reeves (University of North Carolina). Flagtag antibody was purchased
from Eastman Kodak Corp. Zinc-finger DNA binding domains (ZFDs) of
Sp3 (from amino acid 501 to amino acid 697) and Sp4 (from amino acid
616 to amino acid 784) were prepared by subcloning polymerase chain
reaction products into pCITE vector (Novagen, Madison, WI) or pT7–7
vector (obtained from Dr. Stan Tabor, Harvard Medical School). Each
DNA binding domain was tagged with Flag peptide (Kodak) at the C
terminus. Primers used to amplify ZFD-Sp3 are CATATGGGGGAC-
CAACAACATCAAGAAGGA (59 foward) and GGGATCCTCACTTGT-
CATCGTCGTCCTTGTAGTCCTCCATTGTCTCATTTCCAGAAA (39
foward). Primers used to amplify ZFD-Sp4 are CATATGCCTGGCAA-
GAGGCTTCGAAGAGTT (59 forward) and GGGATCCTCACTTGT-
CATCGTCGTCCTTGTAGTCGAATTCTTCCATGTTGGTTGAAC (39
forward). The plasmids were transcribed and translated in vitro to
produce functional zinc-finger DNA binding domains using the Single
Tube System 2 (Novagen, Madison, WI). The resulting proteins were
used for electrophoretic mobility shift assays.
DNase I Footprinting Assays—To examine DNA-protein interactions
in the minimal promoter region, pCAT AX plasmid (19) was digested
with HindIII and filled in with the Klenow fragment in the presence of
[a-32P]dCTP. The labeled DNA was further digested with XbaI (a re-
striction site in the polylinker), and the labeled restriction fragment
was purified by electrophoresis in a 4% non-denaturing polyacrylamide
gel. For DNase I footprinting assays from the opposite end of the
fragment, the order of digestion was reversed so that the XbaI site was
labeled. DNase I digestion and electrophoresis were as described pre-
viously (19). Purified Sp1 transcription factor (0.1–2 fpu), probe (40,000
cpm), and poly(dI-dC) (1 mg) were used in each DNase I digestion
reaction.
Electrophoretic Mobility Shift Assays (EMSAs)—EMSAs were car-
ried out as described previously (19). Sequences of various oligonucleo-
tides are as follows (only the top strand is shown): site A oligonucleotide
(140 bp to 160 bp): GATCCCCCCGGATGTCAGCCCCCCGCGCC; site
B oligonucleotide (11 bp to 122 bp): GATCGCGCTCGCCACGCCCAT-
GCCTC; site C-1 oligonucleotide (221 bp to: 3 bp): GATCACGCCCCGC-
CCCCCTCGCT; site C-2 oligonucleotide (238 bp to 222 bp): GAAT-
TCATTGCAAGCCCCCCC; site C-3 oligonucleotide (229 bp to 215 bp):
GAATTCCCCCCCCACGCCCC. Each binding reaction was carried out
in 20 ml, and contained 10 mM HEPES (pH 7.9), 60 mM KCl, 1 mM
dithiothreitol, 1 mM EDTA, 7% glycerol, and appropriate nuclear ex-
tract or protein (0.1–2 footprint units of Sp1, 6–36 mg of HeLa cell
nuclear extract). Where indicated, excess unlabeled competitor oligonu-
cleotide (20–200-fold excess) and antibodies (1 mg each) against Sp1,
Sp3, Sp4, or Flag peptide was added to the binding mixture.
Transient Expression Assays in Mammalian Tissue Culture Cells—
Alexander cells (human hepatoma), were grown on 10-cm dishes in
minimal essential medium (Life Technologies, Inc.) supplemented with
5% fetal calf serum. When they reached 50–60% confluence, the me-
dium was replaced. Four hours later, CaCl2-DNA coprecipitates (30)
were added: 6 mg of pCAT 5–2, 3 mg of pCMVSp1, Sp3, or Sp4, and an
appropriate amount of pUC18 DNA to total 16 mg of DNA were added
to each dish. The DNA was allowed to remain on the cells for 4 h, after
which the medium was removed, medium containing 20% glycerol was
added for 2 min, and fresh growth medium was added. Cells were
incubated for 48 h. After the plates were gently washed four times with
cold phosphate-buffered saline, the cells were harvested and cell pellets
were resuspended in 150 ml of lysis buffer (100 mM KPO4, pH 7.8, 1 mM
dithiothreitol). Cells were broken by three cycles of freezing and
thawing.
We did not use reporter plasmids as internal controls because their
promoters contain binding sites for Sp1 and related transcription fac-
tors. Therefore, the introduction of Sp1, Sp3, and Sp4 expression vec-
tors into cells would also affect the internal control. Instead, we used a
fixed amount of protein extract for each CAT assay. CAT assays were
conducted by incubating cell extracts containing 40 mg of protein in 200
ml of a reaction mixture containing 0.25 M Tris-HCl (pH 7.8), 50 mM
acetyl CoA, 100 nCi of [14C]chloramphenicol, 5 mM EDTA at 37 °C for
4 h. The acetylation of chloramphenicol was analyzed by silica gel
thin-layer chromatography and quantitated with a Fuji Phosphoimage
Analyzer (Tokyo, Japan). CAT activity was expressed as relative CAT
activity compared with the control (pCAT 5–2 only), and was the aver-
age of six independent experiments.
Transient Expression Assays in Schneider’s Drosophila Line 2 Cells
FIG. 1. The ADH5/FDH minimal pro-
moter. A, nucleotide sequence from 240
bp to 161 bp (see Ref. 18). Potential bind-
ing sites by Sp1, AP2, NF-S, and ETS-1
are marked by solid lines above or below
the sequence. B, summary of DNase I
footprints. The transcription start site is
marked by an arrow. Footprints are
marked by filled ovals or round rectangles
on the depiction of the gene (top solid
line). Below is a tally of sites bound by
purified Sp1 or by nuclear extracts pre-
pared from cells and tissues. Differences
in shading in the region from 290 bp to
161 bp indicate the differences observed
in the footprinting intensity.
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(SL2)—SL2 cells were grown on 10-cm dishes in Schneider cell culture
medium (Life Technologies, Inc.) supplemented with 10% fetal calf
serum. When they reached 50–60% confluence, the cells were trans-
fected. To investigate the role of Sp1, Sp3, and Sp4 on the minimal
prompter, 12 mg of pCAT 5–2, 3 mg of pPac luciferase, varying amounts
of Sp1, Sp2, and Sp3 expression vector (1–9 mg of pPacSp1, pPacSp3,
and pPacSp4) and appropriate amounts of pUC18 DNA to fill the total
DNA amount to 31 mg were transfected into the cells using the CaCl2-
DNA coprecipitation method (30). The pPac vector contains the Dro-
sophila actin promoter and was not affected by the addition of Sp1 and
related factors. The DNA precipitate was allowed to remain on the cells
for 48 h, and then the medium was removed. After the plates were
gently washed four times with cold phosphate-buffered saline, the cells
were harvested and cell pellets were resuspended in 100 ml of 13
reporter lysis buffer (Promega, WI). The cellular extract (10 or 20 ml)
was assayed for luciferase activity (31) to normalize plate to plate
variation in transfection efficiency. Cell extracts representing 200,000
RLU of luciferase activity were then used for CAT assays. CAT assays
were conducted by incubating cell extracts in 174 ml of reaction mixture
containing 0.25 M Tris-HCl (pH 7.8), 2.2 mM acetyl CoA, 100 nCi of
[14C]chloramphenicol, 5 mM EDTA at 37 °C for 8 h. The acetylation of
chloramphenicol was analyzed as described above. CAT activity was
expressed as relative CAT activity compared with the control and was
the average of three or five independent experiments. To investigate the
interaction among the Sp1 multigene family, cells were transfected
with 12 mg of pCAT 5–2, 1 mg of pPac luciferase, 1 mg of pPacSp1,
pPacSp3, or pPacSp4 (3–9 mg) and appropriate amounts of pUC18 DNA
to total 31 mg of DNA, using the CaCl2-DNA coprecipitation method as
above. Extracts representing 67,000 RLU were used for CAT assays.
Site-directed Mutagenesis of pCAT 5–2—To investigate the role of the
cis-elements immediately flanking the transcription start site, muta-
tions were introduced into the Sp1 consensus sequences using a Quick-
Change site-directed mutagenesis kit (Stratagene, La Jolla, CA). pCAT
5–2 M1 (CC at 212/213 bp to AA), pCAT 5–2 M2 (CC at 113/114 bp to
AA), pCAT 5–2 M3 (CC at 212/213 and at 113/114 bp to AA), pCAT
5–2 M4 (CC at 212/213 and 217/218 bp to AA), and pCAT 5–2 M5 (CC
at 212/213, 217/218, and 113/114 bp to AA) were prepared and used
for transient expression assays in Drosophila SL2 cells. Oligonucleo-
tides used in mutagenesis were as follows: M1: CCCCCCACGC-
CCCGAACCCCTCGCTAGGCG and CGCCTAGCGAGGGGTTCGGGG-
CGTGGGGGG; M2: GGCGCTCGCCACGAACATGCCTCCGTCGC and
GCGACGGAGGCATGTTCGTGGCGAGCGCC; M3: oligonucleotides
used to prepare M1 and M2; M4: AAGCCCCCCCCACGAACCGAACC-
CCTCGCT and AGCGAGGGGTTCGGTTCGTGGGGGGGGCTT; M5:
oligonucleotides used to prepare M2 and M4.
Transient Expression Analysis of pCAT 5–2 Mutants—To investigate
the importance of the core cis-elements in transcriptional regulation, 12
mg each of pCAT 5–2, pCAT 5–2 M1, pCAT 5–2 M2, pCAT 5–2 M3,
pCAT 5–2 M4, and pCAT 5–2 M5 were separately cotransfected into
Drosophila SL2 cells with a mixture of the following plasmids: 1 mg of
pPac luciferase, 1 mg of pPacSp1, and appropriate amount of pUC18 (to
total 31 mg of DNA). Transfection and analysis of the reporter gene
activities were carried out as described above. CAT activity was ex-
pressed as relative CAT activity compared with the control and was the
average of four independent experiments.
RESULTS
Sp1 Binding to the ADH5/FDH Minimal Promoter—We
demonstrated that the fragment from 234 bp to 161 bp was
able to promote transcription in all tissue culture cell lines
tested (19), and defined it as an ADH5/FDH minimal pro-
moter. The minimal promoter of the human ADH5/FDH is
GC-rich (82%) and contains several consensus binding se-
quences for Sp1 and for AP2 protein (Fig. 1A; Refs. 18 and 19).
Two Sp1 sites immediately flank the transcription start site.
The region from 240 bp to 122 bp was footprinted by all
nuclear extracts (19).
We characterized the minimal promoter by DNase I foot-
printing analysis using various amounts of Sp1 (Fig. 2). As
shown in Fig. 2, Sp1 can bind to virtually all regions of the
FIG. 2. DNase I footprinting with in-
creasing amounts of Sp1. Sp1, ranging
from 0.1 to 2 fpu, was added to the DNase
I footprinting reactions. A, antisense
strand; B, sense strand. G and G1A indi-
cate Maxam and Gilbert sequencing reac-
tions of the DNA fragment. C, control re-
action without Sp1. The transcription
start site is marked by an arrow.
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ADH5/FDH minimal promoter, and has a very high affinity for
the core cis-elements (boxes B and C) immediately flanking the
transcription site. Sites B (11 bp to 123 bp) and C (24 bp to
227 bp), which immediately flank the transcription start site,
had the highest binding affinity for Sp1: they began to show
footprints with 0.1 fpu (Fig. 2). Site A could be bound by Sp1 at
0.5 fpu (Fig. 2B). Site D (239 bp to 264 bp) was upstream of the
minimal promoter, and was footprinted when Sp1 was above
0.25 fpu. Thus, even though Sp1 could bind to the entire min-
imal promoter, the affinity of the different cis-elements to Sp1
varied by as much as 5–10-fold. Considering their high affinity
to Sp1 and locations relative to the transcription start point,
the core cis-elements may be the most important cis-elements
regulating transcription.
Sp1, Sp3, and Sp4 Regulate ADH5/FDH Minimal Promoter
Activity in Mammalian Cells—Because the members of the Sp1
multigene family share the same binding consensus sequence
(GC box), they may play important roles in the transcriptional
regulation by directly interacting with the core cis-elements
(Fig. 2, sites B and C). Thus, we tested whether the members of
the Sp1 multigene family can regulate the ADH5/FDH gene
through the minimal promoter by cotransfecting the minimal
promoter-CAT fusion construct (pCAT 5–2) and the Sp1, Sp3,
Sp4, and rat Sp1 expression vectors into human Alexander
cells. Sp1 did not alter the promoter activity (Fig. 3), probably
because there was already enough endogenous Sp1 in the cells.
However, rat Sp1 significantly activated transcription. Sp3
repressed the promoter activity by 40%. Surprisingly, Sp4, a
known transcription activator (16, 30), also repressed tran-
scription by 45%. The data indicated that members of the Sp1
multigene family can regulate the transcription of the ADH5/
FDH gene by interacting with the minimal promoter.
Proteins Interacting with the Minimal Promoter in HeLa Cell
Nuclear Extract—We carried out a series of EMSAs to deter-
mine which transcription factors in a HeLa cell nuclear extract
were interacting with the ADH5/FDH minimal promoter. We
specifically tested whether Sp1, Sp3, and Sp4 can indeed in-
teract with the cis-elements on the minimal promoter to give
the transient expression assay data described above (Fig. 3).
Sp1 bound strongly to probe A (140 bp to 161 bp), and the
band was supershifted by the Sp1 antibody (Fig. 4A, lane 2 and
3). HeLa nuclear extract gave two main retarded bands (la-
beled Sp1 and Ku), that could be competed by excess cold probe
(lanes 9–11). One complex could be supershifted by the anti-
body against Sp1 (band Sp1, lanes 4 and 5), indicating that Sp1
in HeLa nuclear extract can interact with probe A. We sus-
pected that the protein which produced the major fast-moving
complex that was observed in all gel mobility-shift assays may
be the Ku antigen, a DNA-binding subunit of the DNA-depend-
ent protein kinase complex. Indeed, the major fast-moving
complex (labeled Ku) was clearly supershifted by the Ku anti-
body (Fig. 4E) (32, 33). Ku is known to bind to the ends of DNA
(34). We will not further discuss this band in the present
report.
Sp1 could also bind to probe B (11 bp to 122 bp) (Fig. 4B). A
similar complex was detected in the HeLa extract, and most of
this band was supershifted by the Sp1 antibody (Fig. 4B).
Antibodies against Sp3 and Sp4 did not shift much of the
Sp1-containing band (Fig. 4B, lanes 6–9), although some ma-
terial was apparently shifted to the wells when larger amounts
of extract were tested. Following a much longer exposure of the
gel, very faint bands in lanes 7 and 9 appeared in a position
similar to the supershifted Sp1-probe-antibody complex, which
may be the Sp3- or Sp4-probe-antibody complex (data not
shown). Probe B could be bound more strongly by Sp1 than was
probe A, judging by the relative intensities of the Sp1 and Ku
bands (Fig. 4, B and E).
Based on DNase I footprint analysis with Sp1, we divided the
upstream footprinted region (237 bp to 22 bp: footprints C 1
C9 in Fig. 2A, and C in Fig. 2B) into three partially overlapping
probes, C-1, C-2, and C-3. Sp1 (and the Ku antigen) were the
major proteins interacting with these probes (Fig. 4, C and D).
Probes C-1 (222 bp to 23 bp) and C-3 (229 bp to 215 bp) bound
strongly to Sp1, while probe C-2 (238 bp to 221 bp) bound
more weakly. We suspect that the presence of two closely
positioned Sp1 binding elements enhanced the interaction be-
tween Sp1 and probe C-1.
Probes B and C-1, the cis-elements immediately flanking the
transcription start site, bound most strongly to Sp1 (Fig. 4E).
Despite the consensus AP2 sites noted above, EMSA did not
give any indication for AP2 binding; none of the retarded bands
formed by the various probes and HeLa extract was able to be
supershifted by the AP2 antibody (data not shown).
Zinc-finger DNA Binding Domains of Sp3 and Sp4 Can Bind
Specifically to the Core cis-Elements—Because Sp3 and Sp4
may be present in low levels in HeLa cells (10), and the size of
the retarded DNA-protein complex or DNA-protein-antibody
complex overlap other bands, we were not able in the experi-
ments shown in Fig. 4 to clearly demonstrate that Sp3 or Sp4
can bind to the minimal promoter. To investigate the possible
interaction between Sp3 and Sp4 and various cis-elements, we
prepared, by in vitro transcription and translation, shorter
versions of the transcription factors that contain only the zinc-
finger DNA binding domains tagged with Flag peptide (named
ZFD-Sp3 and ZFD-Sp4). ZFD-Sp3 and ZFD-Sp4 were able to
FIG. 3. Effects of Sp1, Sp3, and Sp4 on transcription in Alex-
ander cells (of human liver origin). Six mg of pCAT 5–2 was co-
transfected with 3 mg of various expression vectors encoding mamma-
lian transcription factors, all driven by the CMV promoter (pCMVSp1,
pCMVSp3, pCMVSp4, pCMVratSp1). pCAT Basic contained neither
promoter nor enhancer, and served as a negative control. Forty mg of
total cellular protein was used for each CAT assay. The reporter activ-
ities are presented as relative CAT activity, the ratio of CAT activity of
each transfection compared with that of pCAT 5–2 without cotrans-
fected transcription factors, and are the average of six independent
assays. Bars represent standard deviations.
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bind selectively to the probe B and C-1, the two core cis-
elements immediately flanking the transcription start site, as
demonstrated in the EMSA shown in Fig. 5 (A and B, lanes 2
and 5). The retarded bands containing ZFD-Sp3 and ZFD-Sp4
were either supershifted or lost by the addition of antibodies
against Sp3 or Sp4 (Fig. 5, A and B, lanes 3 and 6). Adding the
FIG. 4. EMSA with purified Sp1 and HeLa nuclear extract. One footprint unit of Sp1 or 6 to 36 mg of HeLa nuclear extract was used. A,
probe A (140 bp to 160 bp). B, probe B (11 bp to 122 bp). C, probe C-1 (222 bp to 23 bp). D, probes C-2 (238 bp to 222 bp) and C-3 (229 bp to
215 bp). E, supershifts with antibody to Ku. Sp1-Ab band, Sp1-probe-aSp1 Ab complex; Sp1 band, Sp1-probe complex; Ku band, Ku-probe complex;
Ku-Ab band, Ku-probe-aKu Ab complex; X band, C-1 probe-unknown protein complex; X1, X2 bands, probe-unknown protein complex enhanced
by addition of Ku antibody.
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Flag antibody also resulted in the disappearance of the bands
(Fig. 5, A and B, lanes 4 and 7). The binding of the proteins to
probe B was stronger than to probe C-1, which is in line with
FIG. 5. Binding of Sp3 and Sp4 to
the core cis-elements. A, EMSA with
probe B (11 bp to 122 bp) and ZFD-Sp3
and ZFD-Sp4. B, EMSA with probe C-1
(222 bp to 23 bp) and ZFD-Sp3 and ZFD-
Sp4. In vitro synthesized ZFDs of Sp3 or
Sp4, tagged with Flag peptide, were used
in the binding reactions. In the control
lanes (lane 1 of A and B), rabbit reticulo-
cyte extract with the in vitro synthesized
product of the lacZ gene was used instead.
Where noted, 1 mg of antibodies against
Sp3, Sp4, or Flag peptide was added
(lanes 3, 4, 6, and 7). C, control (lane 1);
ZFD-Ab, supershifted probe-ZFD-antibody
complex; NS, nonspecific probe-protein
complex; ZFD-Sp3, ZFD-Sp3-probe com-
plex; ZFD-Sp4, ZFD-Sp4-probe complex.
FIG. 6. Effects of Sp1, Sp3, and Sp4 on transcription in Dro-
sophila SL2 cells. Twelve mg of pCAT 5–2, 3 mg of pPac luciferase, and
varying amounts of pPacSp1, pPacSp3, and pPacSp4 (1–9 mg) were
cotransfected into Drosophila SL2 cells. Cell extracts representing
200,000 RLU of luciferase (from the internal control pPac luciferase)
were used for CAT activity assays. Data are presented as relative CAT
activity compared with the control pCAT 5–2 without cotransfected
expression vector, and are the average of three independent assays.
Bars represent standard deviations.
FIG. 7. Transcription activation by Sp1 can be repressed by
Sp3 or Sp4 in Drosophila SL2 cells. Cells were transfected with 12
mg of pCAT 5–2, 1 mg of pPac luciferase, 3 mg of pPacSp1, and varying
amounts of pPacSp3 and pPacSp4 (3–9 mg). Cell extracts representing
67,000 RLU of luciferase activity were used for CAT assays. Data are
presented as relative CAT activity compared with the control (12 mg of
pCAT 5–2 1 1 mg of pPacSp1), and are the average of five independent
assays. Bars represent standard deviations.
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data showing that the GGGCGTGG motif (probe B) has a
slightly higher affinity toward Sp3 or Sp4 than to Sp1 (6).
EMSA revealed that ZFD-Sp3 and ZFD-Sp4 were not able to
bind to the cis-elements contained in probes A, C-2, and C-3
(data not shown).
Sp1, Sp3, and Sp4 Regulate ADH5/FDH Minimal Promoter
Activity in Drosophila SL2 Cells, Which Lack Endogenous
Sp1—Since Sp1 and related factors are expressed in virtually
all mammalian cells, and such endogenous expression could
affect the interpretation of cotransfection experiments, we de-
cided to analyze the effects of these transcription factors in
Drosophila SL2 cells, which are known to lack them (35, 36).
We introduced the minimal promoter-CAT fusion plasmid
pCAT 5–2 along with the Drosophila expression vectors
pPacSp1, pPacSp3, and pPacSp4 into Drosophila SL2 cells.
pCAT 5–2 alone was not able to drive transcription at all (Fig.
6, lanes 1 and 11). This demonstrated the lack of a critical
transcription factor essential for the formation of the transcrip-
tion initiation complex. Addition of the Sp1 expression vector,
pPacSp1, drastically increased transcription in a dose-depend-
ent manner (Fig. 6, lanes 2–4); stimulation was 51-fold at 9 mg
of pPacSp1. Sp3 and Sp4 did not significantly stimulate tran-
scription from the ADH5/FDH promoter. We also introduced
pCAT 5–2 (12 mg) with 9 mg each of pPacSp3 and Sp4 into
Schneider cells to investigate the potential interaction between
Sp3 and Sp4 on the minimal promoter. Sp3 and Sp4 gave only
a very weak transcriptional activation, barely detectable over
the background (data not shown). Thus, Sp3 and Sp4 function
very differently than Sp1 in the transcription process.
We further investigated whether transcriptional activation
by Sp1 could be repressed by either Sp3 or Sp4. pCAT 5–2 (12
mg), pPacSp1 (3 mg), and 3–9 mg of pPacSp3 or pPacSp4 were
introduced into Drosophila SL2 cells. Transcription activation
by Sp1 could be clearly repressed by both Sp3 and Sp4 (Fig. 7,
lanes 2–5). Sp3 and Sp4 may abort the formation of the tran-
scriptional initiation complex by competing with Sp1 for the
same core cis-elements.
The Core cis-Elements Are Critical for Transcriptional Acti-
vation by Sp1—We tested the role of the core cis-elements in
transcriptional activation by Sp1, using site-directed mutagen-
esis. We prepared five mutated minimal promoter constructs,
with mutations introduced at one or more Sp1 binding sites
(pCAT 5–2 M1 at 212/213, GGGGCGGG 3 GGTTCGGG;
pCAT 5–2 M2 at 113/114, TGGGCGTGG 3 TGTTCGTGG;
pCAT 5–2 M3 with both previous mutations, at 212/213 and
113/114; pCAT 5–2 M4 at 217/218, and 212/213; pCAT 5–2
M5 at 217/218, 213/212, and 113/114) (Fig. 8A). pCAT 5–2
M1 and pCAT 5–2 M2 constructs showed reduction in tran-
scription by 53% and 78%, respectively (Fig. 8B). Site B (19 to
116 bp) seems to play a more important role in transcription
than site C-1 (217 to 210 bp). In the pCAT 5–2 M3 and M5
constructs, a significant reduction (greater than 70%) in tran-
FIG. 8. The two Sp1 binding core
cis-elements are the critical center in
the transcriptional activation by Sp1.
A, five mutant versions of pCAT 5–2 and
the sites of mutations introduced by site-
directed mutagenesis. B, CAT assay re-
sults of pCAT 5–2 wt and mutant ver-
sions. Twelve mg each of pCAT 5–2 w/t,
pCAT 5–2 M1, pCAT 5–2 M2, pCAT 5–2
M3, pCAT 5–2 M4, and pCAT 5–2 M5
were separately cotransfected with pPac
luciferase (1 mg) and pPacSp1 (1 mg). Cell
extracts representing 67,000 RLU were
used for the CAT assays. Data are pre-
sented as relative CAT activity (% conver-
sion) compared with the control (12 mg of
pCAT 5–2 wt 1 1 mg pPacSp1) and are the
average of four independent assays. Bars
represent standard deviations.
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scription resulted by having two to three mutations introduced
at the core Sp1 binding sites. Comparing the activity of M4
with M1, there is little effect of the second mutation in C-3,
given a mutation in C-1. This is also seen comparing M3 and
M5. Thus, in the context of a promoter with a mutation in C-1,
site C-3 has little or no effect.
Unexpectedly, mutating both sites B and C (in pCAT 5–2 M3
and M5) did not knock out the transcription completely (Fig.
8B). The residual transcription (22–30%) observed in pCAT 5–2
M3 and M5 might be caused by some residual binding of Sp1 to
the mutated elements, or to cis-elements outside of this core.
We investigated the possibility that the newly mutated se-
quence may be recognized by endogenous Drosophila transcrip-
tion factors. We were not able to observe any transcriptional
activation with these mutated constructs in the absence of Sp1,
suggesting that Drosophila transcription factors were not ca-
pable of stimulating these mutated promoters (data not
shown).
DISCUSSION
We investigated the regulation of transcription of the
ADH5/FDH minimal promoter by members of the Sp1 multi-
gene family member. DNase I footprinting analysis and EMSA
showed that the cis-elements on the minimal promoter differ in
their binding affinity toward Sp1 and related transcription
factors; the affinities vary by as much as 5–10-fold. Sp1 can
preferentially bind to the core cis-elements immediately flank-
ing the transcription start site, sites B and C-1, extending from
222 bp to 120 bp. Sp1 is a strong transcriptional activator of
this promoter, acting through these sites. Sp3 and Sp4 do not
significantly activate this promoter, and compete with Sp1 for
the key sites, leading to a reduction in transcription. These
data provide the first demonstration that Sp4 can act as a
repressor.
Analyses of the DNA-protein interactions on the minimal
promoter, using both purified proteins and HeLa cell nuclear
extract, demonstrate that Sp1 is the major transcription factor
binding to the cis-acting elements. Although virtually the en-
tire promoter region can be footprinted by 0.5 fpu of Sp1, the
core cis-elements flanking the transcription start site have the
highest binding affinity toward Sp1 (5–10-fold higher than the
other sites; Figs. 2 and 4). Binding of Sp1 or related factors to
this unique arrangement of cis-acting elements may allow the
nucleosome surrounding the minimal promoter to enter into an
“open” state by actively displacing the histone (37–39). Since
Sp3 and Sp4 were reported to bind to the same cis-elements
that are bound by Sp1 (i.e. GC boxes), we examined the binding
of Sp3 and Sp4 to this promoter. The zinc-finger DNA binding
domains of both Sp3 or Sp4 can bind selectively to the core
cis-elements, but not elsewhere in the minimal promoter (Figs.
4 and 5). Therefore it is very likely that competition among Sp1
multigene family members and the interaction among them are
mainly occurring on the core cis-elements in vivo.
To investigate the roles of Sp1 family members in transcrip-
tional regulation, we carried out transient expression assays
using the minimal ADH5/FDH promoter-CAT fusion con-
structs. In human Alexander cells, which contain endogenous
Sp1, rat Sp1 but not human Sp1 stimulated transcription (Fig.
3), probably because there is already enough endogenous Sp1.
Sp3 inhibited transcription, as might be expected given prior
reports of its function as a repressor (10, 14). Surprisingly,
given its usual function as a transcriptional activator (14), Sp4
also inhibited transcription (Fig. 3).
To better analyze the transcriptional roles of the Sp1 family
members, we carried out further assays in Drosophila SL2
cells, which do not express endogenous Sp1 (35, 36). pCAT 5–2,
a minimal promoter construct, was not able to drive transcrip-
tion at all in these SL2 cells (Fig. 6). Addition of Sp1 (by
cotransfection) potently activated transcription, more than 50-
fold. This demonstrates that Sp1 is a critical factor in tran-
scriptional initiation at this promoter. Mutations in the core
cis-elements resulted in substantial reductions of the tran-
scription (Fig. 8), indicating that these elements are critical for
transcriptional initiation. Considering the particular location
of Sp1 binding sites relative to the transcription start site and
other reports on the interaction between Sp1 and TBP or
TAF110 (11, 26, 40–43), Sp1 may play a critical role in the
formation or recruitment of the transcription initiation com-
plex onto the core promoter (Fig. 9). Synergistic activation by
Sp1 is often made possible by having two or more Sp1 sites
located next to each other in a promoter (10, 44). However, the
two core cis-elements in the ADH5/FDH promoter did not
show synergism (Fig. 8).
We investigated whether Sp3 or Sp4 could activate tran-
scription in the absence of Sp1, using SL2 cells. There was little
or no transcription, even in the presence of the highest amount
of cotransfected expression vectors (Fig. 6). This suggests that
Sp3 and Sp4 lack the ability to interact with TBP or TAF110 in
this promoter context. We also tested whether transcriptional
activation by Sp1 can be affected by Sp3 or Sp4. Transcrip-
tional activation by Sp1 was repressed by Sp3 or Sp4 (Fig. 7).
The transcriptional repression by Sp3 or Sp4 is surprisingly
similar to the results obtained with the mutant constructs
where one of the two core cis-elements is destroyed by site-
directed mutagenesis. Because Sp3 or Sp4 cannot themselves
activate transcription on this particular promoter, the occupa-
tion of one of the two sites by Sp3 or Sp4 and the other by Sp1
is like the situation where only one site is occupied by Sp1 due
to the mutation introduced. By having one site occupied by Sp3
(or Sp4), or by having one Sp1 binding site destroyed, a signif-
icant drop in transcription can result. The drop might be more
FIG. 9. A hypothetical model of the transcriptional regulation
by the Sp1 multigene family at the ADH5/FDH minimal pro-
moter. B and C-1 are core cis-elements immediately flanking transcrip-
tion start point (Tsp, marked by an arrow). TBP, TATA-binding protein.
TAF110, TBP-associated factor 110. Double arrows indicate the inter-
action between transcription factors (Sp1, Sp3, Sp4) and TBP or
TAF110. Arrows under transcription indicate the degree of transcrip-
tional activation.
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dramatic if higher levels of Sp3 or Sp4 were induced by the
expression vectors; others have reported that the levels
achieved are not high (10). In contrast, even at 20 ng of added
DNA, pPac-Sp1 expresses Sp1 sufficiently to activate tran-
scription strongly (10).
These data suggest that Sp3 and Sp4 can act as repressors by
competing with Sp1 for binding to the core cis-elements and
preventing the formation of the transcription initiation com-
plex. Sp4 had not previously been shown to repress transcrip-
tion. Based on these findings, we propose a hypothetical model
on the transcriptional regulation at the ADH5/FDH minimal
promoter (Fig. 9). The two core cis-elements are the critical
center for transcriptional initiation and activation by Sp1.
These elements can be preferentially bound by Sp1, Sp3, and
Sp4. If only Sp1 occupies these elements, it can interact with
TBP or TAF110 and can promote strong transcription. By hav-
ing two core binding sites for Sp1, transcription activation by
Sp1 is ensured and strong transcription is made possible. If the
core sites are occupied by Sp3 or Sp4 alone, the interaction
between the transcription factor with one or more components
of general transcription machinery is either absent or weak,
which can result in little or no transcriptional activation. If one
site is occupied by Sp1 and the other by Sp3 or Sp4, the
transcription activation will be relatively low compared with
the situation where two sites are occupied by Sp1 only.
Therefore, the cellular content of Sp1, Sp3, and Sp4 and their
interactions on the minimal promoter may be critical factors
influencing transcription of the ADH5/FDH gene in various
human tissues (22, 23). This model may also be applicable to
many housekeeping genes with GC boxes located either in the
proximal promoter or around the transcription start site, as is
the case in the ADH5/FDH gene.
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